ANI Pharmaceuticals, Inc. ("ANI") and Alimera Sciences, Inc. ("Alimera" or the "Company") today jointly announced that they have scheduled the closing of their transaction pursuant to the companies' ...

Boeing shares are downgraded, Vice President Kamala Harris opposes the pending $14.1 billion sale of U.S. Steel to Japan’s ...

evaluating the company’s 9-valent Human Papillomavirus (HPV) vaccine, GARDASIL ® 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) in Japanese males ages 16 to 26 years. The trial met its ...

Vaxcyte unveiled what analysts called “stunning” phase 1/2 data for its 31-valent pneumococcal vaccine candidate that, if replicated in a large pivotal study, could pose a serious threat to ...

Tuesday, Vaxcyte, Inc. (NASDAQ:PCVX) released topline results from the Phase 1/2 study evaluating the safety, tolerability and immunogenicity of VAX-31, the company's 31-valent pneumococcal ...

Sincero is a charming high-street restaurant with high-concept dishes from the team behind Buono in Melbourne’s bayside. Lilijana embraces the Swedish “fika” tradition of slowing down for ...

The 21-valent product – formerly known as V116 – covers a wider range of Streptococcus pneumoniae serotypes than any of MSD’s earlier vaccines and eight that are not covered by any other ...

Gene Therapy for GD2 Expressing Solid Tumors is under clinical development by Bellicum Pharmaceuticals and currently in Phase I for Medulloblastoma.

Bexmarilimab is under clinical development by Faron Pharmaceuticals and currently in Phase II for Myelodysplastic Syndrome.